home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  3rd Annual Microarray Data Analysis  
  September 12, 2003

Biotechnology

 
     
  Cambridge Healthtech Institute, Wyndham Baltimore Inner Harbor
September 21-23, 2003


The use of microarrays is booming in basic and pharmaceutical research, because of the value gained by measuring the expression of numerous genes in parallel. The exploding amount of data generated by high throughput experiments, however, can become a minefield of options and opportunities for mistakes, particularly when it comes to statistical interpretation. Thorough attention is now being paid to experimental design and to methodologies for interpreting microarray data. Further progress is needed. Researchers have gained respect for the value of replicates and more sophisticated statistical analysis methods beyond simply looking for genes up- or down-regulated beyond some threshold value. Experience has also shown that adopting standards for microarray experiment annotation, data representation and normalization can be crucial for converting mounds of data into useful insight and statistically significant conclusions. Benefit from the knowledge and expertise of researchers who are leading the way to ensure the right experiments are carried out, and the most value is obtained from data being generated.
 
 
Organized by: Cambridge Healthtech Institute
 
Deadline for Abstracts: .
 
Registration: To register visit: www.healthtech.com/2003/dbi/reg.aspor call 617-630-1300.
E-mail: chi@healthtech.com
 
  Posted by:   Lisa Cardinale  
Host: wks140.healthtech.com
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.